Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Tripthi Kamath"'
Autor:
Amanda Zheutlin, Miles Ott, Ran Sun, Natalia Zemlianskaia, Craig S. Meyer, Meagan Rubel, Jennifer Hayden, Breno Neri, Tripthi Kamath, Najat Khan, Sebastian Schneeweiss, Khaled Sarsour
Publikováno v:
Vaccines, Vol 10, Iss 9, p 1458 (2022)
The durability of immune responses after COVID-19 vaccination will drive long-term vaccine effectiveness across settings and may differ by vaccine type. To determine durability of protection of COVID-19 vaccines (BNT162b2, mRNA-1273, and Ad26.COV2.S)
Externí odkaz:
https://doaj.org/article/220b22c2b2924f9d9dbd7a4b216ca1d5
Autor:
Jennifer M. Polinski, Andrew R. Weckstein, Michael Batech, Carly Kabelac, Tripthi Kamath, Raymond Harvey, Sid Jain, Jeremy A. Rassen, Najat Khan, Sebastian Schneeweiss
Publikováno v:
JAMA network open. 5(3)
Vaccination against the SARS-CoV-2 virus is critical to control the pandemic. Randomized clinical trials demonstrated efficacy of the single-dose Ad26.COV2.S COVID-19 vaccine, but data on longer-term protection in clinical practice and effectiveness
Autor:
Amanda Zheutlin, Miles Ott, Ran Sun, Natalia Zemlianskaia, Meagan Rubel, Jennifer Hayden, Breno Neri, Tripthi Kamath, Najat Khan, Sebastian Schneeweiss, Khaled Sarsour
BackgroundIntrinsic durability of immune responses elicited by COVID-19 vaccines will drive vaccine effectiveness long-term across settings and may differ by vaccine type. We aimed here to determine durability of protection of three COVID-19 vaccines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1987fb55c154a0e17ac099ec3b57183a
https://doi.org/10.1101/2022.01.05.22268648
https://doi.org/10.1101/2022.01.05.22268648
Autor:
Najat S. Khan, Raymond A. Harvey, Sebastian Schneeweiss, Jennifer M. Polinski, Michael Batech, Jeremy A. Rassen, Andrew Weckstein, Carly A. Kabelac, Sid Jain, Tripthi Kamath
ImportanceVaccination against the SARS-CoV-2 virus is critical to control the pandemic. Randomized trials demonstrated efficacy of the single-dose Ad26.COV2.S COVID vaccine but data on longer-term protection in clinical practice and effectiveness aga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fcdccc47c02688f0418fa5b4cdca848
https://doi.org/10.1101/2021.09.10.21263385
https://doi.org/10.1101/2021.09.10.21263385
Publikováno v:
Open Forum Infectious Diseases
Background COVID-19 remains a threat to public health, with over 30 million cases in the US alone. As understanding of optimal patient care has improved, treatment guidelines have continued to evolve. This study characterized real-world trends in tre
Autor:
Tripthi Kamath, Klaus-Uwe Kirchgässler, Eric Van Ganse, Jenny Chia, Philippe Bonniaud, Vincent Cottin, Manon Belhassen, Maeva Nolin, F. Dalon, Paolo Spagnolo
Publikováno v:
Epidemiology.
Autor:
Manon Belhassen, Maeva Nolin, Philippe Bonniaud, Klaus-Uwe Kirchgässler, Tripthi Kamath, Paolo Spagnolo, F. Dalon, E. Van Ganse, Jenny Chia, Vincent Cottin
Publikováno v:
A23. ILD PROGNOSIS AND BIOMARKERS I.
Autor:
Manon Belhassen, E. Van Ganse, Maeva Nolin, Tripthi Kamath, Paolo Spagnolo, Jenny Chia, F. Dalon, Vincent Cottin, Philippe Bonniaud, Klaus-Uwe Kirchgässler
Publikováno v:
Revue des Maladies Respiratoires Actualités. 13:189-190
Introduction La pirfenidone et le nintedanib sont les seuls medicaments approuves pour le traitement de la fibrose pulmonaire idiopathique (FPI). L’objectif de cette etude etait de decrire l’utilisation des ressources de sante (URS) des patients
Autor:
Anthony Masaquel, Nicholas Sicignano, Marjolaine Gauthier-Loiselle, Eric Q. Wu, Roy Nitulescu, Christopher Gallagher, Brian Barnett, Tripthi Kamath, Raluca Ionescu-Ittu, Annie Guerin, Kenneth More
Publikováno v:
Cancer Research. 75:P5-21
Background Trastuzumab reduces the risk of relapse in women with HER2+ early stage breast cancer. Yet, little information exists on the timing of trastuzumab initiation and its association with relapse and survival outcomes in these patients. The stu
Autor:
Christopher Gallagher, Elizabeth Butts, Marjolaine Gauthier-Loiselle, Eric Q. Wu, Raluca Ionescu-Ittu, Tripthi Kamath, Anthony Masaquel, Nicholas Sicignano, Brian Barnett, Roy Nitulescu, Kenneth More, Annie Guerin
Publikováno v:
SpringerPlus
Purpose The NSABP Trial B-31 and NCCTG Trial N9831 (B-31/N9831 trials, Romond et al. in N Engl J Med 353:1673–84, 2005. doi:10.1056/NEJMoa052122; Perez et al. in J Clin Oncol 32:3744–52, 2014. doi:10.1200/JCO.2014.55.5730) established the efficac